Free Trial

Northern Trust Corp Makes New Investment in Nutex Health Inc. (NASDAQ:NUTX)

Nutex Health logo with Medical background

Northern Trust Corp acquired a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 6,312 shares of the company's stock, valued at approximately $200,000. Northern Trust Corp owned 0.12% of Nutex Health as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. World Investment Advisors acquired a new position in Nutex Health during the fourth quarter valued at approximately $217,000. XTX Topco Ltd acquired a new position in shares of Nutex Health in the fourth quarter valued at approximately $251,000. Russell Investments Group Ltd. acquired a new position in shares of Nutex Health in the fourth quarter valued at approximately $672,000. Legato Capital Management LLC boosted its holdings in shares of Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock valued at $1,004,000 after buying an additional 6,697 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in shares of Nutex Health by 12.6% in the fourth quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after buying an additional 3,826 shares during the period. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Stock Performance

NUTX stock traded down $1.38 during trading hours on Friday, reaching $122.02. The stock had a trading volume of 342,237 shares, compared to its average volume of 73,642. The stock has a market capitalization of $679.16 million, a PE ratio of -13.00 and a beta of 0.04. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The stock has a 50-day simple moving average of $132.63 and a 200 day simple moving average of $74.59. Nutex Health Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $184.28.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. The firm had revenue of $211.79 million during the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

Analyst Ratings Changes

Several research firms have recently weighed in on NUTX. Maxim Group upped their price target on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a report on Tuesday, May 20th. Benchmark upped their price target on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a report on Thursday, May 15th. Finally, Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd.

Read Our Latest Analysis on Nutex Health

Insider Buying and Selling at Nutex Health

In related news, CFO Jon Christian Bates bought 1,000 shares of the business's stock in a transaction dated Tuesday, April 8th. The stock was bought at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the purchase, the chief financial officer now owns 4,888 shares in the company, valued at $399,887.28. This represents a 25.72% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 38.52% of the company's stock.

About Nutex Health

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Stories

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines